The Use of Long-term Antibiotics for Suppression of Bacterial Infections

Molly Horne1, Ian Woolley1,2, Jillian S Y Lau1,2

  • 1Faculty of Medicine, Nursing, and Health Sciences, Monash University, Clayton, Victoria, Australia.

Insights

Suppressive antibiotic therapy is used for incurable infections, often with prosthetic material. This review examines its risks, including adverse effects and antibiotic resistance, and calls for standardized terminology for long-term use.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Clinical Medicine

Background:

  • Suppressive antibiotic therapy is used for infections presumed incurable by standard treatment or source control.
  • Patients often have comorbidities and retained prosthetic material, necessitating prolonged or indefinite antibiotic courses.
  • Lack of clear guidelines contributes to extended antibiotic use, with poorly characterized risks.

Purpose of the Study:

  • To review evidence for suppressive antibiotic therapy in four common indications.
  • To identify gaps in the current literature regarding its use.
  • To explore the known and potential risks associated with prolonged antibiotic exposure.

Main Methods:

  • Narrative review of existing literature.
  • Analysis of evidence for suppressive antibiotic therapy in specific clinical scenarios.
  • Examination of risks, including adverse drug effects, antibiotic resistance, and microbiome disruption.

Main Results:

  • Evidence for suppressive antibiotic therapy in four common indications was presented.
  • Gaps in the current literature were identified.
  • Known and potential risks of prolonged antibiotic exposure were explored.

Conclusions:

  • Suppressive antibiotic therapy is a complex treatment for hard-to-treat infections.
  • Further research is needed to fully characterize risks and optimize treatment strategies.
  • A standardized term for long-term suppressive antibiotic use is recommended to improve evidence quality.

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
177
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.8K
Antibiotic Selection00:57

Antibiotic Selection

Overview
53.1K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
115
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
363
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
110